Evaluating sorafenib (SORA-2) as second-line treatment for unresectable hepatocellular carcinoma: a European retrospective multicenter study
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2025
|
| In: |
Cancers
Year: 2025, Volume: 17, Issue: 6, Pages: 1-25 |
| ISSN: | 2072-6694 |
| DOI: | 10.3390/cancers17060972 |
| Online Access: | Resolving-System, kostenfrei: http://dx.doi.org/10.3390/cancers17060972 |
| Author Notes: | Christian Möhring, Moritz Berger, Farsaneh Sadeghlar, Xin Zhou, Taotao Zhou, Malte Benedikt Monin, Kateryna Shmanko, Sabrina Welland, Friedrich Sinner, Birgit Schwacha-Eipper, Ulrike Bauer , Christoph Roderburg, Angelo Pirozzi, Najib Ben Khaled, Peter Schrammen, Lorenz Balcar, Matthias Pinter, Thomas J. Ettrich, Anna Saborowski, Marie-Luise Berres, Enrico N. De Toni, Tom Lüdde, Lorenza Rimassa, Ursula Ehmer, Marino Venerito, Iuliana-Pompilia Radu, Ingo G.H. Schmidt-Wolf, Arndt Weinmann, Arndt Vogel, Matthias Schmid, Jörg C. Kalff, Christian P. Strassburg and Maria A. Gonzalez-Carmona |
| Physical Description: | Online Resource |
|---|---|
| ISSN: | 2072-6694 |
| DOI: | 10.3390/cancers17060972 |